HNN3.0

Project cooperationUpdated on 1 December 2025

B-cell mediated immune responses in health and disease.

Principal Investigator at Helmholtz Munich and TUM

Munich, Germany

About

Our group has extensive expertise in studying the development and regulation of antibody-secreting cells, germinal center and memory B cells using mouse models of immunization, parasitic infection, and allergic inflammation. We employ a broad range of advanced tools and approaches, including in vivo CRISPR/Cas9 screens, in vitro B cell activation assays, sgRNA-mediated gene inactivation in naive and effector B cells, multicolor flow cytometry, and genetically engineered mouse models for targeted gene deletion. Additionally, we integrate transcriptomic and epigenetic profiling, and collaborate with computational scientists for high-dimensional data analysis to dissect molecular pathways controlling B cell differentiation and function. Our work combines mechanistic studies with translational insights to better understand humoral immunity in health and disease.

Topic

  • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
  • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Type

  • Partner seeks Consortium/Coordinator

Organisation

Helmholtz Munich and TUM

University

Munich, Germany

Similar opportunities